Search Results for keywords:"revocation"

The U.S. Department of Commerce has completed an expedited review of the countervailing duty (CVD) order on steel wheels from China, which are 12 to 16.5 inches in diameter. They found that removing this order would likely result in the continuation or recurrence of subsidies that are unfair to U.S. producers. This decision is part of the sunset review process, which revisits such orders to decide if they should be continued. The Commerce Department did not receive any significant responses from Chinese manufacturers, leading to this expedited review and conclusion.

The President of the United States has issued a memorandum detailing the order of succession for officials in the Office of Personnel Management (OPM) who can act as the Director if both the Director and Deputy Director are unable to serve. The order starts with the Chief of Staff, followed by the General Counsel, and continues through other key OPM positions. However, anyone currently serving in an acting capacity in these roles cannot automatically become the acting Director. The President also reserves the right to choose a different acting Director if needed, and this memorandum revokes a previous memorandum from December 10, 2020. The memo does not create any new legal rights for or against the government.

The U.S. Department of Commerce conducted an expedited sunset review on the countervailing duty order for aluminum wire and cable from China. They concluded that if this duty order were removed, it would likely result in the continuation or recurrence of unfair subsidies. This review did not receive adequate responses from the Chinese government or other interested parties, leading to the expedited process. The decision will maintain the duty order to prevent potential subsidies at the stated rates.

The Food and Drug Administration (FDA) has decided to revoke the use of the color additive FD&C Red No. 3 in foods and ingested drugs. This decision was based on evidence showing that FD&C Red No. 3 can cause cancer in male rats, which under the law, makes it unsafe. Although the risk to humans is considered low, the FDA is compelled by law to remove this additive because it has been linked to cancer in animals. The order will take effect on January 15, 2027, but objections can be submitted until February 18, 2025, if anyone is adversely affected by this ruling.

The Drug Enforcement Administration (DEA) decided to revoke the DEA Certificate of Registration for Dr. Willard J. Davis, a doctor in Texas, because he lost his state license to practice medicine, which means he can no longer handle controlled substances legally in Texas. The Texas Medical Board suspended Dr. Davis's medical license on May 16, 2024, and it remained suspended at the time of the decision. Since having a valid state medical license is necessary to maintain DEA registration for dispensing controlled substances, his registration was revoked, and any pending applications related to the registration were denied. This decision will be effective starting April 28, 2025.

The Drug Enforcement Administration (DEA) has decided to revoke Jason Lee Ray's DEA Certificate of Registration because he cannot legally handle controlled substances in Wyoming. This decision follows the suspension of his Wyoming physician assistant license by the Wyoming Board of Medicine. The DEA's decision emphasizes the necessity of being authorized at the state level to dispense controlled substances to maintain a DEA registration. Any applications by Jason Lee Ray to renew or modify his registration are also denied, effective January 29, 2025.

The State Department has officially revoked the designation of Ansarallah, also known by other names, as a Foreign Terrorist Organization. This decision was made in coordination with the Attorney General and the Secretary of the Treasury. The revocation is carried out under the authority of the Immigration and Nationality Act. This change will be documented in the Federal Register.

The International Trade Commission announced that it will conduct a full review to decide if removing the antidumping duty order on certain large diameter line pipes from Japan might cause harm to U.S. industries. This review, required by the Tariff Act of 1930, will follow an earlier finding that responses from both domestic and interested parties were adequate. A detailed schedule for the review will be released later, and the Commission will provide access to the proceedings and rules on its official website.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Dr. Margaret Sprague, proposing to revoke her Certificate of Registration due to her lack of authority to handle controlled substances in California. This decision followed the revocation of her state medical license by the Medical Board of California. Dr. Sprague did not request a hearing and was deemed in default, admitting the allegations against her. Consequently, the DEA revoked her registration and denied any future applications for registration in California.

The Drug Enforcement Administration (DEA) has decided to revoke the registration of Dr. Kevin Petersen, meaning he can no longer prescribe or handle controlled substances. This decision came after it was found that his medical license in Nevada, where he practiced, had expired and was then revoked, which automatically made him ineligible to maintain his DEA registration for handling such substances. Dr. Petersen did not contest this action by requesting a hearing, leading the DEA to proceed with its final decision. This order will officially take effect on January 29, 2025.